Core Viewpoint - The stock of Shangmei Co., Ltd. (02145) has increased by over 3%, currently trading at 96.4 HKD with a transaction volume of 49.12 million HKD, driven by positive market developments and strong performance indicators in the beauty sector [1] Group 1: Company Performance - According to Qingyan Intelligence, the total GMV of the top 20 beauty brands on Douyin is expected to exceed 3 billion CNY by September 2025, capturing a market share of 17.6%, which represents a year-on-year growth of 38.59% [1] - Han Shu, a leading brand under Shangmei, continues to lead with a GMV exceeding 500 million CNY [1] - Huatai Securities reports that Shangmei's revenue and profit growth in the first half of the year have been impressive, with strong growth momentum observed in August as the main brand Han Shu expands into multiple product categories [1] Group 2: Market Expansion - The company has successfully launched multiple brands, including Guoguang White, Bread Superhero, and NAN Beauty, since the beginning of the second half of the year, indicating effective brand expansion [1] - The ability to incubate and operate multiple brands and product categories has been initially validated, suggesting potential for further growth if this capability continues to be replicated [1] - The internal organizational structure is characterized by high efficiency and strong execution capabilities, laying a solid foundation for future growth [1]

Core Viewpoint - The stock of Shumei Co., Ltd. (02145) has increased by over 3%, currently trading at 96.4 HKD with a transaction volume of 49.12 million HKD, indicating positive market sentiment towards the company [1] Group 1: Company Performance - According to Qianyan Intelligence, the total GMV of the top 20 beauty brands on Douyin is expected to exceed 3 billion CNY by September 2025, capturing a market share of 17.6%, which represents a year-on-year growth of 38.59% [1] - Han Shu, a leading brand under Shumei, has achieved over 500 million CNY in GMV, maintaining its position at the forefront of the market [1] - Huatai Securities reports that Shumei's revenue and profit growth in the first half of the year have been impressive, with strong growth momentum observed in August as the company continues to expand its product lines, including next-generation essence and fragrance body wash [1] Group 2: Market Expansion and Strategy - The company has successfully launched multiple brands, including Guangguang White, Bread Superhero, and NAN Beauty, since the second half of the year, indicating effective brand expansion strategies [1] - The ongoing multi-brand and multi-category incubation and operational capabilities of the company have been preliminarily validated, suggesting potential for further growth if these capabilities can be replicated [1] - The internal organizational structure of the company is characterized by high efficiency and strong execution, providing a solid foundation for future growth [1]

Core Insights - The Chinese beauty industry is experiencing a significant transformation, with many brands exiting the market while others are rapidly launching new sub-brands to adapt to changing consumer demands and market conditions [1][8][24]. Group 1: Industry Trends - The beauty industry is facing a "winter" period, leading to the exit of several brands such as Qiaodi Shanghui and Jing Sheng Zhi Yuan [1]. - Despite the challenges, there is a surge in new brand launches, indicating a robust response from leading companies [1][8]. - Major players like Shangmei Co., Beitaini, and Polaroid are actively developing multiple sub-brands to enhance their market presence [8][24]. Group 2: Company Strategies - Shangmei Co. has launched three new brands this year, including NAN beauty, a high-end anti-aging brand Tazu, and a baby care brand [10][11]. - Beitaini is set to introduce a new acne treatment brand, Ansta, which has been in development for three years [15][16]. - Polaroid is considering overseas acquisitions to fill gaps in its product offerings, targeting markets such as baby care and men's grooming [17][24]. Group 3: Market Positioning - The multi-brand strategy allows companies to cater to diverse consumer needs across different demographics, enhancing their competitive edge [24][29]. - Companies are focusing on leveraging their main brand strengths to create differentiated sub-brands that address specific market segments [27][30]. - The trend of building a multi-brand matrix is becoming standard among leading beauty companies in China, moving away from a single-brand dominance [28][39]. Group 4: Growth Strategies - Companies are employing both internal brand incubation and external acquisitions as primary methods for expanding their brand portfolios [29][33]. - Internal incubation allows companies to innovate and meet emerging consumer demands effectively, while acquisitions provide immediate access to established brands and markets [32][38]. - The balance between these strategies is crucial for sustained growth and market relevance in a competitive landscape [39].

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The report highlights the strong performance of the retail and beauty sectors, with a focus on the growth potential of domestic brands in the beauty industry [6][44] - The medical beauty segment is expected to see new growth drivers from innovative products, while the cosmetics sector is benefiting from the rise of domestic brands and consumer trends towards self-care [6][44] Summary by Sections 1. Market Review - The beauty and personal care index rose by 6.84% in August 2025, ranking 15th among all primary industries, underperforming the broader market which saw a 7.97% increase [12][15] - In the medical beauty sector, notable stock performances in August included Meili Tianyuan Medical Health (+32.4%), Kedi (+31.7%), and Yisi Health (+22.7%) [16] - In the cosmetics sector, leading performers were Jiaheng Home (+55.4%), Shuiyang Co. (+36.3%), and Ruoyu Chen (+29.0%) [20] 2. Medical Beauty - Jinbo Biological's "Recombinant Type III Humanized Collagen Freeze-Dried Fiber" received drug auxiliary material registration, marking a significant advancement in the medical field [26] - Longzi Co. plans to acquire 67.5% of Chongqing Milan Baiyu for 92.475 million yuan, with performance commitments ensuring net profits of at least 9.29 million yuan, 9.89 million yuan, and 11.83 million yuan from 2025 to 2027 [28] 3. Cosmetics - Proya plans to list in Hong Kong, potentially becoming the first A+H share beauty company, which would enhance its international business development [32] - Proya's investment in Huazhi Xiao will strengthen its position in the makeup sector, leveraging Huazhi Xiao's content operations and overseas channels [35] - The launch of the NAN beauty brand by Shangmei Co. represents a strategic move to enhance its presence in the mid-to-high-end market [40] 4. Investment Recommendations - The report recommends focusing on leading domestic beauty brands that are continuously evolving and capitalizing on high-growth segments [44] - Key recommendations include Shangmei Co., Maogeping, Proya, and Runben Co., with an emphasis on their strong market positions and growth potential [48]

Core Viewpoint - The main brand, Han Shu, is solidifying its leading position in the Douyin beauty sector and is experiencing rapid growth on other e-commerce platforms [1][2] Group 1: Brand Performance - Han Shu maintained the top position in Douyin beauty rankings for Chinese brands, achieving this for two consecutive years in 2023 and 2024, and has held this ranking every month in the first eight months of 2023 [1] - The brand's competitive strength is highlighted by proactive adjustments to its live broadcasting and self-broadcasting models amid increasing industry competition [1] - In addition to Douyin, Han Shu's GMV on platforms like Tmall, Vipshop, Pinduoduo, and Kuaishou grew by over 20% in the first half of the year, indicating effective multi-platform collaboration [1] Group 2: New Growth Drivers - The mid-to-high-end baby and child brand, Yi Ye, reported a 147% year-on-year revenue increase in the first half of the year, with its revenue share rising to 9.6%, establishing it as the company's second growth curve [2] - Yi Ye's expansion from baby skincare to a full range of efficacy skincare for ages 0-18 is expected to further enhance its growth potential, with a projected compound annual growth rate of around 60% over the next three years [2] - The launch of the new color cosmetics brand, NAN beauty, in mid-August, is expected to enrich the company's multi-brand matrix, supported by collaborations with top makeup artists and e-commerce experts [2] Group 3: Long-term Growth Potential - The company's multi-brand and multi-category strategy is becoming increasingly robust, with several new brands and product categories in development [2] - The success of the multi-brand approach is attributed to effective incentive and management mechanisms, including internal empowerment and a results-oriented culture, as well as an open attitude towards external collaborations [2] Group 4: Profit Forecast and Investment Recommendation - The company's earnings forecast has been slightly adjusted, with expected earnings per share for 2025-2027 at 2.78, 3.55, and 4.37 RMB respectively [2] - A target price of 103.21 HKD is set for 2025, based on a 34x PE ratio, maintaining a "buy" rating [2]

Investment Rating - The report maintains a "Buy" rating for the company [5][10] Core Views - The main brand, Han Shu, has solidified its leading position in the Douyin beauty sector and is experiencing rapid growth on other e-commerce platforms, with a strong performance across multiple platforms [9] - The second growth curve has formed with the mid-to-high-end baby and child brand, Yi Ye, showing a significant revenue increase of 147% year-on-year, contributing to the company's growth [9] - The company launched a new high-end professional makeup brand, NAN beauty, which is expected to enhance its multi-brand strategy [9] - The company's multi-brand and multi-category layout is becoming increasingly mature, supported by effective management and incentive mechanisms [9] Financial Forecast and Investment Recommendations - The earnings per share (EPS) forecasts for 2025-2027 are adjusted to 2.78, 3.55, and 4.37 RMB respectively, with a target price of 103.21 HKD based on a 34x PE ratio for 2025 [4][10] - The company’s revenue is projected to grow significantly, with 2023 revenue at 4,191 million RMB and expected to reach 12,411 million RMB by 2027, reflecting a compound annual growth rate [4][10] - The gross margin is expected to remain stable around 75%, while the net profit margin is projected to improve from 11.0% in 2023 to 14.0% in 2027 [4][10]

Group 1 - The company reported a robust revenue growth of 17.29% year-on-year, achieving an operating income of 4.108 billion yuan in H1 2025 [1] - The net profit attributable to the parent company reached 524 million yuan, reflecting a significant increase of 30.65% year-on-year [1] - The gross margin for H1 2025 was 75.52%, a slight decrease of 0.99 percentage points, while the net profit margin improved by 1.74 percentage points to 13.52% [1] Group 2 - The main brand, Han Shu, generated revenue of 3.344 billion yuan in H1 2025, marking a 14.3% increase, with significant sales from the Hong Man Yao and X Peptide series [2] - The second brand, Newpage, saw a remarkable revenue growth of 146.5% year-on-year, reaching 397 million yuan, achieving its annual sales target for 2024 [2] - The company is actively enhancing its online sales strategy, with self-operated online channels generating 3.421 billion yuan in revenue, a 24.6% increase, and accounting for 83.3% of total revenue [2] Group 3 - The company is expected to achieve net profits of 1.025 billion yuan, 1.286 billion yuan, and 1.566 billion yuan for the years 2025, 2026, and 2027, respectively, with corresponding PE ratios of 32, 26, and 21 [3]

Core Viewpoint - The company reported strong performance for H1 2025, with revenue of 4.11 billion yuan, a year-on-year increase of 17.3%, and a net profit of 560 million yuan, up 34.7% year-on-year, falling within the upper range of previous forecasts [1][2]. Revenue Breakdown - The multi-brand matrix continues to grow, with online revenue increasing by 20.1% year-on-year in H1 2025. By brand, revenue for 韩束, Newpage 一页, 红色小象, 一叶子, and other brands were 3.34 billion, 400 million, 160 million, 90 million, and 120 million yuan respectively, with year-on-year changes of +14.3%, +146.5%, -8.7%, -29.0%, and +2.9% [1]. - By channel, online and offline revenues were 3.81 billion and 270 million yuan respectively, with year-on-year changes of +20.1% and -10.6% [1]. - By segment, skincare, maternal and infant care, and other categories generated revenues of 3.42 billion, 560 million, and 130 million yuan respectively, with year-on-year changes of +10.2%, +65.0%, and +124.3% [1]. Profitability Metrics - The net profit margin increased by 1.7 percentage points year-on-year to 13.5%. The gross margin for H1 2025 was 75.5%, down 1 percentage point year-on-year, while the expense ratio was 63.2%, up 0.03 percentage points [2]. Brand Performance - The main brand 韩束 showed steady growth, maintaining the top position in beauty brands on Douyin, with GMV growth of +15.5% on Douyin and +26.1% on Tmall. Star products like 红蛮腰 sold over 15 million units, and the X 肽 series generated over 200 million yuan in sales [2]. - The Newpage 一页 brand rapidly expanded, targeting skincare products for ages 0-18, with significant sales during the 618 shopping festival, achieving GMV growth of +190% on Douyin and +106% on Tmall [2]. Brand Portfolio Expansion - The company has a robust pipeline of brands across multiple segments, including a sensitive skin care brand in collaboration with 昆药集团, a high-end skincare brand 聚光白, and a high-end anti-aging brand TAZU. Additionally, it is preparing to launch IP co-branded products in maternal and infant care and new hair care and makeup brands [3]. Profit Forecast and Investment Rating - The company is expected to achieve net profits of 1.11 billion, 1.41 billion, and 1.76 billion yuan for 2025-2027, representing year-on-year growth of 42.3%, 26.5%, and 24.8% respectively. The latest closing price corresponds to PE ratios of 30, 24, and 19 times for the respective years, maintaining a "buy" rating [3].

Core Viewpoint - Proya (603605.SH) has become the first domestic beauty brand to surpass 10 billion in revenue but is currently facing pressure from slowing performance [1][2] Financial Performance - In the first half of 2025, Proya reported revenue and net profit attributable to shareholders of 5.362 billion and 799 million respectively, representing year-on-year growth of 7.21% and 13.8% [1] - The second quarter showed a significant slowdown, with revenue of 3.003 billion, a year-on-year increase of only 6.49%, down over 30 percentage points compared to the same period in 2024 [1] - The main brand's revenue declined slightly by 0.08% to 3.979 billion in the first half of 2025, compared to a growth rate of 38% in the same period last year [5] Marketing Strategy - Proya has significantly increased its marketing expenditures, signing at least three top celebrities as brand ambassadors in 2025, which is more than the total of the past five years [1][9] - Marketing expenses reached 2.659 billion in the first half of 2025, a year-on-year increase of 13.64% [7] - The company is focusing on cost control, with operating costs down over 5% year-on-year to 1.427 billion [1][11] Competitive Landscape - Proya is set to compete with its peer, Shiseido's parent company, Up Beauty (2145.HK), which reported a revenue growth rate of 16% in the first half of 2025 [3][15] - Proya's market share is currently around 2%, indicating significant room for growth compared to mature markets [6] Future Plans - Proya is planning to list on the Hong Kong Stock Exchange, aiming to enhance its international strategy and financing capabilities [13][14] - The company has identified potential acquisition targets to boost its performance, with a goal of increasing its overall revenue to 35 billion from its own brands and 15 billion through acquisitions over the next decade [15][16]

Core Viewpoint - The company reported strong revenue and profit growth for the first half of 2025, with a 17.3% increase in revenue and a 30.6% increase in net profit attributable to shareholders, indicating robust operational performance and market positioning [1][2]. Financial Performance - The company achieved a revenue of 4.11 billion RMB and a net profit of 520 million RMB in the first half of 2025, with an EPS of 1.32 RMB [1]. - The gross margin decreased by 1 percentage point to 75.5%, while the expense ratio remained stable at 63.2% [2]. - Inventory increased by 7.2% year-on-year to 680 million RMB, with inventory turnover days decreasing by 5 days to 249 days [2]. - Operating net cash flow grew significantly by 77.5% to 390 million RMB [2]. Brand and Product Development - The main brand, Han Shu, maintained its leading position on the Douyin platform, ranking first among beauty brands and expanding its product line with new offerings [3]. - The company is actively pursuing a multi-brand strategy, launching new brands in various categories, including skincare, maternal and infant care, and cosmetics [3]. - New brands such as An Min You for sensitive skin and a high-end anti-aging brand TAZU are in development, alongside collaborations with well-known IPs for maternal and infant products [3]. Market Strategy and Outlook - The company is expected to benefit from its multi-brand strategy, which is anticipated to inject new growth momentum and enhance operational efficiency and profit margins [4]. - Profit forecasts for 2025, 2026, and 2027 have been adjusted upward to 1.16 billion RMB, 1.47 billion RMB, and 1.83 billion RMB, respectively, reflecting confidence in the company's growth trajectory [4].